Yarrow Bioscience, Inc. (YARW)

Market Cap	88.40M +7,031.0%
Revenue (ttm)	n/a
Net Income	n/a
EPS	n/a
Shares Out	2.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,498
Open	28.00
Previous Close	28.05
Day's Range	27.55 - 32.10
52-Week Range	14.03 - 74.47
Beta	2.01
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About YARW

Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company’s candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves’ disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2021
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: YARW
• Website: https://www.yarrowbioscience.com

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jul 29, 2026

Data Sources Report a data error